Genetic variability of lipoprotein(a) controls vascular inflammation/redox signalling and predicts adverse cardiovascular outcomes in coronary artery disease N.
Polkinghorne MD., Xie C., Chauhan J., Baragetti A., Patel P., Kotanidis C., Akoumianakis I., De Araujo E., Krasopoulos G., Walcot N., Badi I., Channon K., Guzik T., Norata GD., Antoniades C.